AIM ImmunoTech to Host Investor Update Webcast on Wednesday, July 14th at 11:00 AM ET

Rhea-AI Summary

On July 6, 2021, AIM ImmunoTech Inc. (NYSE American: AIM) announced an upcoming investor update webcast scheduled for July 14, 2021, at 11:00 a.m. Eastern Time. The session will cover recent achievements and future milestones. Investors are encouraged to submit their questions via email before the call. The webcast can be accessed through the company’s website, and a replay will be available until July 14, 2022. AIM ImmunoTech is focused on developing therapeutics for various cancers, immune disorders, and viral diseases, including COVID-19.

OCALA, Fla., July 06, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it will host an investor update webcast at 11:00 a.m. Eastern Time on Wednesday, July 14, 2021, to discuss recent accomplishments and upcoming milestones. Investors and other interested parties are invited to submit questions to management prior to the call's start via email to aim@crescendo-ir.com.

The webcast may be accessed at https://www.webcaster4.com/Webcast/Page/2605/41875 or on the Company’s website at https://aimimmuno.com/events-presentations/. For those unable to participate at that time, a replay of the webcast will be available until Thursday, July 14, 2022 on the Company’s website.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Contacts:

Crescendo Communications, LLC
Phone: 212-671-1021
Email: aim@crescendo-ir.com

AIM ImmunoTech Inc
Phone: 800-778-4042
Email: IR@aimimmuno.com

FAQ

When will AIM ImmunoTech's investor update webcast take place?

The investor update webcast for AIM ImmunoTech is scheduled for July 14, 2021, at 11:00 a.m. Eastern Time.

How can I submit questions for the AIM ImmunoTech investor webcast?

Questions for the AIM ImmunoTech investor webcast can be submitted via email to aim@crescendo-ir.com before the call.

Where can I access the AIM ImmunoTech investor update webcast?

The AIM ImmunoTech investor update webcast can be accessed at https://aimimmuno.com/events-presentations/.

Will there be a replay available for AIM ImmunoTech's webcast?

Yes, a replay of the AIM ImmunoTech webcast will be available until July 14, 2022, on the company's website.

What is the focus of AIM ImmunoTech's research?

AIM ImmunoTech focuses on developing therapeutics to treat various cancers, immune disorders, and viral diseases, including COVID-19.